Identitate

Flecainide Di-Nitroso impurity

Nu este indicat · C17H18F6N4O5

01Identitate

Lazychem IDLC-15343
CAS RNNu este indicat
PubChem CID167728410
Molecular formulaC17H18F6N4O5
Molecular weight472.34 g/mol
IUPAC nameN-Nitroso-N-((1-nitrosopiperidin-2-yl)methyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide
InChIKeyZJBZDWZKPVBTAV-UHFFFAOYSA-N

02Structură și stereochimie

Two-dimensional chemical structure of Flecainide Di-Nitroso impurity
Two-dimensional structure for the PubChem identity linked to this record. Confirm the identifiers before analytical use.

The parsed structure contains 2 rings, includes aromatic atoms, includes aliphatic carbon, contains at least one halogen atom, contains an N-nitroso substructure. These statements are calculated from the published structure string.

Defined stereocentres0
Ring count2
Secondary amines0
Tertiary amines1
SMILESO=C(N(N=O)CC1N(N=O)CCCC1)C2=CC(OCC(F)(F)F)=CC=C2OCC(F)(F)F
InChINu este indicat

03Stereochemistry

The published structure contains 0 defined and 1 unassigned tetrahedral stereocentre. The exact wedge and dash depiction is shown above.

Defined centres0Structure assigned
Unassigned centres1Structure unspecified
Assignment statusUnassignedExact published identity
Tetrahedral upper bound≤ 2Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04Statut în India

Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.

05Denumiri și relații

API și medicament părinte

Flecainide

Impurități și compuși înrudiți

Denumiri și relații

    06Surse